Published online Apr 26, 2020. doi: 10.12998/wjcc.v8.i8.1515
Peer-review started: January 10, 2020
First decision: February 29, 2020
Revised: March 27, 2020
Accepted: April 4, 2020
Article in press: April 4, 2020
Published online: April 26, 2020
Processing time: 103 Days and 5.8 Hours
Ulcerative colitis (UC), also known as chronic nonspecific UC, is an inflammatory bowel disease characterized by diffuse colonic mucosal inflammation. The incidence and prevalence of UC have risen markedly, and the disease seriously affects the quality of life of patients, and poses a great burden on the world health care infrastructure and economy.
We present a 60-year-old man who had ulcerative colitis for more than 10 years, with recurrent abdominal pain, bloody diarrhea with mucopurulent stool. The treatments with sulfasalazine, mesalazine, and traditional Chinese medicine were not effective, and herbs-partitioned moxibustion (HPM) was then applied at “Zhongwan” (RN12), “Tianshu”(ST25), and “Qihai” (RN6) once a day for about 30 min, 3 times per week, for 6 mo.His main clinical symptoms of abdominal pain, bloody diarrhea with mucopurulent stool gradually improved, and the mucosa had nearly healed, as observed under endoscopy by the 6th mo. The patient’s condition was alleviated without relapsing during the subsequent 3-mo follow-up period. HPM showed a significant effect in the treatment of ulcerative colitis in this case, and the effect would help the patient to maintain remission for at least 3 mo.
A series of symptoms of this UC patient significantly improved with the treatment of HPM.
Core tip: Ulcerative colitis (UC) is an inflammatory bowel disease characterized by diffuse colonic mucosal inflammation. Herbs-partitioned moxibustion (HPM) is a warm stimulation therapy based on traditional acupuncture theory. HPM was applied at “Zhongwan” (RN12), “Tianshu” (ST25), and “Qihai” (RN6) in an UC patient. The results showed that HPM can improve the clinical symptoms of this UC patient and the healing of colonic mucosa and help the patient maintain remission for at least 3 mo with no side effects. It can be a typical complementary and alternative therapy for UC.